These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26920104)

  • 1. Improved pharmacokinetic profile of levornidazole following intravenous infusion of 750mg every 24h compared with 500mg every 12h in healthy Chinese volunteers.
    Cao Y; Wu X; Chen Y; Guo B; Yu J; Cao G; Zhang J; Shi Y; Zhang Y
    Int J Antimicrob Agents; 2016 Mar; 47(3):224-8. PubMed ID: 26920104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Pharmacodynamics of Levornidazole in Patients With Intra-abdominal AnaerobicInfection.
    Wu H; Xie S; Yu J; Chen Y; Wu J; Guo B; Zhu Z; Zhou Y; Wang Z; Zhang J
    Clin Ther; 2018 Sep; 40(9):1548-1555. PubMed ID: 30146271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis.
    Guo B; He G; Wu X; Yu J; Cao G; Li Y; Fan Y; Chen Y; Shi Y; Zhang Y; Zhang J
    Clin Ther; 2017 Jul; 39(7):1336-1346. PubMed ID: 28619503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of injected ornidazole compared to its enantiomer levornidazole in healthy Chinese subjects.
    Liu Y; Zhang Y; Xue W; Wang J; Bai W; Wang T; Liu Y; Tang K; Qin J; Li K; Wang X
    Int J Clin Pharmacol Ther; 2023 Dec; 61(12):543-550. PubMed ID: 37840522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis.
    Cao Y; Li Y; Guo B; Zhang J; Wu X; Yu J; Cao G; Fan Y; Wu H
    Int J Antimicrob Agents; 2023 Apr; 61(4):106754. PubMed ID: 36773938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of levornidazole and its metabolites in human plasma and urine by ultra-performance liquid chromatography-mass spectrometry.
    Cao Y; Zhao M; Wu X; Guo B; Chen Y; Yu J; Cao G; Zhang J; Shi Y; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():119-27. PubMed ID: 24953495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilis.
    Hu J; Zhang J; Chen Y; Liang W; Wu S
    Clin Ther; 2017 Apr; 39(4):828-836. PubMed ID: 28363695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis.
    Wu H; Wang Z; Wang Y; Yu J; Fan Y; Li Y; Wang J; Cao G; Guo B; Chen Y; Liu X; Bian X; Wu J; Li H; Wu X; Zhang J
    Infect Dis Ther; 2021 Jun; 10(2):911-923. PubMed ID: 33826105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
    Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
    Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjects.
    Yang L; Sunzel M; Xu P; Edeki T; Wilson D; Li J; Li H
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):681-91. PubMed ID: 26152131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter randomized controlled clinical study on levornidazole and sodium chloride injection in the treatment of pelvic anaerobic infections].
    Ma L; Zhang YZ; Zheng YL; Wang ZH; Xu YD; Kong LN
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):754-6. PubMed ID: 21176556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia.
    Cheng SL; Wu RG; Chuang YC; Perng WC; Tsao SM; Chang YT; Chang LW; Hsu MC
    J Microbiol Immunol Infect; 2019 Oct; 52(5):743-751. PubMed ID: 30616912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
    Sunzel M; Learoyd M; Li J; Li Y; Ngo N; Edeki T
    Int J Antimicrob Agents; 2015 Dec; 46(6):682-8. PubMed ID: 26545441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of chiral inversion and pharmacokinetics of laevo-ornidazole by high-performance liquid chromatography.
    Mu LL; Cheng ZN; Guo X; Luo X; Yu P
    J Clin Pharm Ther; 2013 Feb; 38(1):31-5. PubMed ID: 23167572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteers.
    Wu GL; Shentu JZ; Zhou HL; Zhu MX; Hu XJ; Liu J; Wu LH
    Drugs R D; 2015 Mar; 15(1):63-70. PubMed ID: 25644122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 8-hour intravenous infusion of NXY-059: a phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers.
    Cheng YF; Jiang J; Hu P; Reinholdsson I; Guo W; Asenblad N; Nilsson D
    Clin Ther; 2008 Dec; 30(12):2342-53. PubMed ID: 19167593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rifampicin pretreatment on the transport across rat intestine and oral pharmacokinetics of ornidazole in healthy human volunteers.
    Kumar YS; Ramesh S; Rao YM; Paradkar AR
    Drug Metabol Drug Interact; 2007; 22(2-3):151-63. PubMed ID: 17708065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties and safety profile of histamine dihydrochloride injection in Chinese healthy volunteers: a phase I, single-center, open-label, randomized study.
    Li J; Huang X; Wang Q; Jing S; Jiang H; Wei Z; Zang Y; Liu Y; Zhao L; Fang Y; Feng W
    Clin Ther; 2015 Oct; 37(10):2352-64. PubMed ID: 26276501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of ornidazole concentration in saliva and serum of healthy volunteers].
    Jiang Y; Liu HC; Wu X; Feng CZ; Chang P; Zhang XH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2108-10. PubMed ID: 20855263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.